Literature DB >> 19898974

Large-cell neuroendocrine carcinoma of the ampulla of Vater.

Z Stojsic1, D Brasanac, D Bilanovic, O Mitrovic, R Stevanovic, I Boricic.   

Abstract

Large-cell neuroendocrine carcinoma is a high-grade neuroendocrine carcinoma, originally described in the lung. The tumor rarely occurs in extrapulmonary sites like the gastrointestinal tract, and only few examples have been described in the ampulla of Vater. A new case of large-cell neuroendocrine carcinoma of the ampulla of Vater in a 60-year-old man is reported. After pancreatoduodenectomy, macroscopic examination revealed ulcerated tumor in the region of the ampulla of Vater. Microscopically, the tumor exhibited organoid, predominantly nested growth pattern, consisting of large, polygonal cells with pleomorphic nuclei. Average number of mitoses was 36 per 10 high-power fields. Small and large areas of necrosis were identified. Immunohistochemically, the tumor cells were positive for synaptophysin, chromogranin A, PGP 9.5, neuron-specific enolase, pancytokeratin, CK8 and somatostatin and negative for CK7, CK20, S-100, TTF-1, HMB-45, CD117, E-cadherin and regulatory peptides. Ki-67 proliferative index was 41%. Histone deacetylase (HDAC) analysis showed almost identical results for HDAC1, HDAC2 and HDAC3--60, 60.3 and 61%, respectively. Two months after surgery, liver metastases occurred, confirming highly aggressive behavior of large-cell neuroendocrine carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898974     DOI: 10.1007/s12032-009-9350-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  24 in total

1.  An immunohistochemical and ultrastructural study of case of small-cell neuroendocrine carcinoma in the ampullary region of the duodenum.

Authors:  A B Sarker; Y Hoshida; S Akagi; K Hayashi; I Murakami; H J Jeon; K Takahashi; T Akagi
Journal:  Acta Pathol Jpn       Date:  1992-07

Review 2.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 3.  Primary cutaneous carcinosarcoma: case report with expanded immunohistochemical analysis.

Authors:  Dimitrije Brasanac; Ivan Boricic; Vera Todorovic; Nada Tomanovic
Journal:  Int J Dermatol       Date:  2008-05       Impact factor: 2.736

4.  High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.

Authors:  Hind Nassar; Jorge Albores-Saavedra; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2005-05       Impact factor: 6.394

5.  Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.

Authors:  Viola Baradari; Alexander Huether; Michael Höpfner; Detlef Schuppan; Hans Scherübl
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

6.  Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity.

Authors:  Shi-Xu Jiang; Tetuo Mikami; Atsuko Umezawa; Makoto Saegusa; Toru Kameya; Isao Okayasu
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

7.  Valproic acid induces Notch1 signaling in small cell lung cancer cells.

Authors:  Christopher S Platta; David Yü Greenblatt; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Surg Res       Date:  2008-04-10       Impact factor: 2.192

8.  Histone deacetylase inhibitors specifically kill nonproliferating tumour cells.

Authors:  Andrew Burgess; Astrid Ruefli; Heather Beamish; Robyn Warrener; Nicholas Saunders; Ricky Johnstone; Brian Gabrielli
Journal:  Oncogene       Date:  2004-09-02       Impact factor: 9.867

9.  Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

Authors:  Jinru Shia; Laura H Tang; Martin R Weiser; Baruch Brenner; N Volkan Adsay; Edward B Stelow; Leonard B Saltz; Jing Qin; Ron Landmann; Gregory D Leonard; Deepti Dhall; Larissa Temple; Jose G Guillem; Philip B Paty; David Kelsen; W Douglas Wong; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

Review 10.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

View more
  5 in total

1.  Biologic correlates and significance of axonogenesis in prostate cancer.

Authors:  Adriana Olar; Dandan He; Diego Florentin; Yi Ding; Gustavo Ayala
Journal:  Hum Pathol       Date:  2014-02-28       Impact factor: 3.466

2.  Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis.

Authors:  Traian Dumitrascu; Simona Dima; Vlad Herlea; Victor Tomulescu; Mihnea Ionescu; Irinel Popescu
Journal:  Langenbecks Arch Surg       Date:  2012-04-03       Impact factor: 3.445

3.  Report of two cases of large cell neuroendocrine carcinoma of duodenal ampulla with contrasting outcomes following pancreaticoduodenectomy according to the use of adjuvant chemotherapy.

Authors:  Naoya Imamura; Atsushi Nanashima; Masahide Hiyoshi; Yoshiro Fujii
Journal:  Int J Surg Case Rep       Date:  2017-01-17

4.  Ampullary Large-Cell Neuroendocrine Carcinoma, a Diagnostic Challenge of a Rare Aggressive Neoplasm: A Case Report and Literature Review.

Authors:  Eleni Karlafti; Maria Charalampidou; Georgia Fotiadou; Ioanna Abba Deka; Georgia Raptou; Filippos Kyriakidis; Stavros Panidis; Aristeidis Ioannidis; Adonis A Protopapas; Smaro Netta; Daniel Paramythiotis
Journal:  Diagnostics (Basel)       Date:  2022-07-25

5.  Histopathology of gastrointestinal neuroendocrine neoplasms.

Authors:  Kenichi Hirabayashi; Giuseppe Zamboni; Takayuki Nishi; Akira Tanaka; Hiroshi Kajiwara; Naoya Nakamura
Journal:  Front Oncol       Date:  2013-01-22       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.